Zimmer Biomet Holdings, Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-09-08. Between them they name 2 people, with 1 appointment and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
Mr. Thornal will be departing from the Company, effective on September 30, 2026.
Departing: Suketu Upadhyay, Chief Financial Officer, effective 2026-04-28
On April 22, 2026, Suketu Upadhyay informed Zimmer Biomet Holdings, Inc. (the "Company") of his intention to resign from the position of Chief Financial Officer and Executive Vice President - Finance, Operations and Supply Chain of the Company, effective as of April 28, 2026, to pursue a new professional opportunity.
Appointed: Paul Stellato, Chief Financial Officer
In connection with Mr. Upadhyay's departure, Paul Stellato, Vice President, Controller and Chief Accounting Officer, has been appointed to act, along with continuing to serve in his current role, as the Company's interim Chief Financial Officer, effective upon Mr. Upadhyay's departure, until a permanent successor is named.
Find people with the same kind of experience as the Chief Financial Officer at Zimmer Biomet Holdings, Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Zimmer Biomet Holdings, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Zimmer Biomet Holdings, Inc. is in the news or changes leadership.
Get an alert when Zimmer Biomet Holdings, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Zimmer Biomet Holdings, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.